EBOV_Bundi_L_F1 Sequence:GAA GGA and 5 more items

The University of Nebraska, a state institution under the Board of Regents, awarded a purchase order valued at $776.76 to Integrated DNA Technologies Inc., a Chicago, Illinois-based vendor, on June 4, 2026. The contract encompasses the procurement of six oligonucleotide sequences and fluorescent-labeled probes related to Ebola virus Bundibugyo research materials. Delivery is specified to the University of Nebraska Medical Center General Supply facility located at 601 South Saddle Creek Road in Omaha, Nebraska, with a completion date of June 10, 2026. Payment terms are Net 30 with freight prepaid and delivered to destination.

The line items consist of four DNA sequences (designated EBOV_Bundi_L_F1, EBOV_Bundi_L_R1, EBOV_Bundi_L_F2, and EBOV_Bundi_L_R2) individually priced between $65.94 and $67.74, and two fluorescent probes (EBOV_Bundi_L_P1 and EBOV_Bundi_L_P2) each priced at $255.00, all ordered in single-unit quantities. The vendor is required to acknowledge acceptance within ten days of the order date and include packing slips clearly marked with the purchase order number on all shipments. This purchase order is classified as a standard procurement transaction managed through the University of Nebraska Medical Center's Accounts Payable department.